Abstract

Background/Aims: As risk of colorectal neoplasm is varied even in persons with “average-risk,” risk evaluation and tailored screening are needed. This study aimed to evaluate the risk factors of high-risk adenoma (HRA) in healthy individuals and determine the characteristics of advanced neoplasia (AN) among individual polyps.Methods: Asymptomatic adults who underwent the first lifetime screening colonoscopy at the Seoul National University Hospital Healthcare System Gangnam Center (SNUH GC) were recruited from 2004 to 2007 as SNUH GC Cohort and were followed for 10 years. Demographic and clinical characteristics were compared between the subjects with and without AN (≥10 mm in size, villous component, and/or high-grade dysplasia and/or cancer) or HRA (AN and/or 3 or more adenomas). For individual polyps, correlations between clinical or endoscopic features and histologic grades were evaluated using a decision tree method.Results: A total of 6,047 subjects were included and 5,621 polyps were found in 2,604 (43%) subjects. Advanced age, male sex, and current smoking status were statistically significant with regards to AN and HRA. A lower incidence of AN was observed in subjects taking aspirin. In the decision tree model, the location, shape, and size of the polyp, and sex of the subject were key predictors of the pathologic type. A weak but significant association was observed between the prediction of the final tree and the histological grouping (Kendall's tau-c = 0.142, p < 0001).Conclusions: Advanced neoplasia and HRA can be predicted using several individual characteristics and decision tree models.

Highlights

  • Colon cancer is the third most prevalent cancer and the second leading cause of cancer-related deaths worldwide [1]

  • This study aimed to evaluate the risk factors of high-risk adenoma (HRA) in healthy individuals and determine the characteristics of advanced neoplasia (AN) among individual polyps

  • Male sex, and current smoking status were statistically significant with regards to AN and HRA

Read more

Summary

Introduction

Colon cancer is the third most prevalent cancer and the second leading cause of cancer-related deaths worldwide [1]. Early detection is key to colorectal cancer treatment. Stages of colon cancer usually require less extensive treatment and can result in better clinical outcomes [2, 3]. Most colorectal cancers can be prevented by early detection and removal of precursor colorectal adenomas [3,4,5,6]. Colonoscopy is one of the most sensitive and effective diagnostic modalities that can directly visualize colorectal lesions and remove premalignant adenomatous polyps or early cancers. Colonoscopy requires a skilled examiner and is associated with significant costs, inconvenience, and procedurerelated adverse events. These limitations of colonoscopy may decrease adherence to screening tests [7]

Objectives
Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call